183 related articles for article (PubMed ID: 1788805)
1. [The problems of modern transfusion science].
Vorob'ev AI; Dabberkha NM
Ter Arkh; 1991; 63(7):4-9. PubMed ID: 1788805
[No Abstract] [Full Text] [Related]
2. [Developments in blood transfusion].
Krusius T; Porkka K
Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306
[No Abstract] [Full Text] [Related]
3. [Everyone and nobody has the responsibility for the future of plasma products].
Sjölin S
Lakartidningen; 1996 Nov; 93(46):4137, 4139. PubMed ID: 8984263
[No Abstract] [Full Text] [Related]
4. Panel Discussion. Millennium Festival of Medicine--Transfusion 2020--18 October 2000.
Fogden M; Whitehorn K; Starr D; Persaud R; Hannaford R; Barbara J; Love E; Robinson A; Ferguson E; Turner G; Wallington T; Klein H; Franklin I; Fry R
Transfus Med; 2001 Apr; 11(2):136-45. PubMed ID: 11583001
[No Abstract] [Full Text] [Related]
5. Sustaining life twice. Will umbilical cord blood replace bone marrow?
Breton JH
Adv Nurse Pract; 2000 Mar; 8(3):92, 95-6, 108. PubMed ID: 11107358
[No Abstract] [Full Text] [Related]
6. [Blood component therapy today].
Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Sirchia G
Haematologica; 1991 Jun; 76 Suppl 3():405-10. PubMed ID: 1752540
[No Abstract] [Full Text] [Related]
7. Current practices in transfusion medicine.
Borker A; Warrier RP
Indian Pediatr; 2001 Mar; 38(3):227-30. PubMed ID: 11255297
[No Abstract] [Full Text] [Related]
8. [Modern problems of transfusion-infusion therapy].
Kolesnikov IS; Ryzhkov SV
Voen Med Zh; 1977 Nov; (11):38-41. PubMed ID: 339522
[No Abstract] [Full Text] [Related]
9. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine.
Gyopar AF; Loertscher R; Guttman RD; Tchervenkov JI
Transplantation; 1993 May; 55(5):1199-202. PubMed ID: 8497904
[No Abstract] [Full Text] [Related]
10. Inactivation of pathogens in blood and blood products.
Ben-Hur E
Med Health R I; 1998 Dec; 81(12):396-9. PubMed ID: 9884539
[No Abstract] [Full Text] [Related]
11. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.
Goodrich RP; Edrich RA; Li J; Seghatchian J
Transfus Apher Sci; 2006 Aug; 35(1):5-17. PubMed ID: 16935562
[TBL] [Abstract][Full Text] [Related]
12. Next century's academic clinical research development in blood and marrow transplants requires continental organizational development.
Van Hoef ME
Bone Marrow Transplant; 1999 Dec; 24(11):1265. PubMed ID: 10642821
[No Abstract] [Full Text] [Related]
13. Decreasing the risk of allogenic blood in the 21st century.
Popovsky MA; O'Neill EM; Cannon M
Med Health R I; 1998 Dec; 81(12):392-5. PubMed ID: 9884538
[No Abstract] [Full Text] [Related]
14. [Rational substitution with stored blood and blood components].
Krüger KJ; Gürtler LG
Dtsch Med Wochenschr; 1995 Apr; 120(17):627-8. PubMed ID: 7736963
[No Abstract] [Full Text] [Related]
15. Fifty years of blood transfusion.
Gunson HH; Dodsworth H
Transfus Med; 1996; 6 Suppl 1():1-88. PubMed ID: 8870182
[No Abstract] [Full Text] [Related]
16. Passage to India.
Kiser K
Minn Med; 2007 Mar; 90(3):10-1. PubMed ID: 17432747
[No Abstract] [Full Text] [Related]
17. [The safety of blood and blood products].
Löwer J
Internist (Berl); 1994 Oct; 35(10):929-33. PubMed ID: 8002228
[No Abstract] [Full Text] [Related]
18. Blood and marrow transplant: it's not just for cancer.
Eisenberg S
ONS Connect; 2012 Nov; 27(11):22. PubMed ID: 23316526
[No Abstract] [Full Text] [Related]
19. [The risk of substitution therapy with blood and blood products].
Baumgarten R
Z Arztl Fortbild (Jena); 1994 Jan; 88(1):3-4. PubMed ID: 8154136
[No Abstract] [Full Text] [Related]
20. [Tests for donors of blood and bone marrow].
Taniwaki K; Itoh M; Misawa M; Hara H
Rinsho Byori; 1995 Jul; Suppl 99():102-10. PubMed ID: 7474414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
